Diasorin Gets FDA 510(k) Clearance for New Multiplexing Platform
Diasorin received FDA 510(k) clearance for its new Liaison Plex platform and first panel of tests, the Liaison Plex Respiratory Flex Assay.
Category: Respiratory Disease
Respiratory Disease
Latest
Respiratory Disease
Latest
New Test Aids Cystic Fibrosis Patients
Researchers developed a urine test to measure the severity of the serious disease cystic fibrosis and assess the effect of new treatments.
Respiratory Disease
Latest
New Biomarker May Lead to Improved Diagnosis Asthma & COPD
Researchers have identified a protein leakage related to chronic airway diseases that could help determine the severity of asthma and COPD.
Thermo Fisher, NanoPin Collaborate to Develop Analytical Workflow for Infectious Disease Diagnosis and Patient Monitoring
NanoPin’s diagnostic platform using Thermo Fisher’s advanced LC-MS technology will create sensitive clinical assays for infectious disease.
Read MorePulmonary Fibrosis Foundation Launches Industry Consortium to Identify Biomarkers in Pulmonary Fibrosis
The Pulmonary Fibrosis Foundation has announced a new collaboration that could speed up the development of targeted treatments for individuals with idiopathic pulmonary fibrosis.
Read More
Exact Diagnostics Launches Control for Molecular-Based Respiratory Panel Tests
Routine use of the EDX RP positive run control enables laboratories to meet the requirements of their individualized quality control plans, including evaluation of reagent lot changes and new shipments.
Read More
FDA Clears Applied BioCode Respiratory Pathogen Panel
The panel tests nasopharyngeal swabs for the most common respiratory viruses and bacteria.
Read More
FDA Approves QuantiFeron-TB Gold Plus Test for Liaison Platforms
The test enables highly automated screening for latent tuberculosis.
Read More
Mologic Launches Clinical Trial to Identify Early Signs of COPD
The Headstart system is designed for home monitoring and integrates a simple, easy-to-use diagnostic with a reader and mobile phone app to capture patient-specific health data.
Read More
Cost-Effective Tests for Lyme Disease and TBRF
IGeneX’s new BCA assays are simple and cost-effective tests that give either a positive or negative result for exposure to Borrelia spp.
Read More
Owlstone Medical Provides Breath Biopsy Analysis to Study of Immune-Mediated Diseases
The company will receive funding to provide the breath biopsy component of a research initiative designed to provide new insights into the mechanisms of response and nonresponse to treatment for seven immune-mediated diseases.
Read More
Molecular QC for Rifampicin-Resistant Mycobacterium Tuberculosis
Positive and negative controls are designed to help laboratories deliver reliable MTB-RIF testing results.
Read MoreLophius Biosciences Closes $3.4 Million Financing Round for TB Detection Assay
The funding will enable Lophius to expand clinical performance data and finalize design of the assay for use on automated platforms.
Read More
Self-Monitoring Solution in Mobile App Can Help Patients Manage Uncontrolled Asthma
A study by Karolinska Institute researchers shows that an algorithm used in a mobile phone app can efficiently manage uncontrolled asthma.
Read More
New Biomarker May Uncover Uncontrolled Asthma
Study subjects with uncontrolled asthma had substantially higher levels of local IL-26 in their airways, when compared with subjects with controlled asthma.
Read More
Roche Expands Global Access Program to Include Diagnostics for Hepatitis, Human Papillomavirus, and Tuberculosis
Access to innovative diagnostic solutions will contribute to the World Health Organization’s infectious disease elimination goals.
Read More
FDA Clears Respiratory Panel That Can Detect More Than 20 Pathogens
The panel is the first offering in a deep and broad pipeline of assays planned for QIAstat-Dx in the United States.
Read More
University of Manchester and Owlstone Medical Awarded £250,000 to Advance Asthma Diagnostics
The study will collect breath samples from asthmatic patients and healthy controls to analyze breath-based biomarkers.
Read More